You work for a retail company that is looking to implement artificial intelligence to increase sales as a recent business performance management review showed a decrease in overall sales. The company wants to use data collected on consumer buying habits and use predictive analysis to help make product recommendations to customers. You are the senior business analyst and have been asked to perform an ethical canvas on the use of AI in consumer data.
Your team has been tasked with providing an ethics canvas for the use of artificial intelligence. For the implementation of AI in business analytics, use Microsoft Word to create and submit an ethics canvas like this document. Click for more options Make sure to include the following in your canvas:
The ethical implications of using AI to make product recommendations to customers.
How AI addition to business analysis could impact the business performance system (BPM).
Implementing artificial intelligence to increase sales
Artificial intelligence (AI) has gone a long way toward changing people`s lives, influencing everything from voice recognition to the potential for self-driving cars. In particular, it has become especially prevalent in marketing, making it simpler and more effective than ever to use data for targeted advertisements and to create robust profiles of customers and influence consumer behavior. However, with the rise of artificial intelligence in marketing comes a variety of associated ethical risks. Marketers must be aware of the potential for bias present in supposedly impartial artificial intelligence. They must take steps to ensure the responsible use of artificial intelligence, including respecting consumer privacy, ensuring the accuracy of data, and preventing algorithmic bias.
urosemide and sodium-induced diuresis one of the mechanisms responsible for the increase in digoxin clearance due to sodium loading was diminished passive proximal back diffusion of filtered and secreted digoxin. reported that diuresis caused a 70% increase in digoxin clearance and a 20% decrease in serum digoxin levels in 10 patients who were taking digoxin for atrial fibrillation and who did not have congestive heart failure. Mechanisms that have been identified for renal excretion of digoxin include glomerular filtration, tubular secretion and proximal tubular reabsorption of digoxin. When the sodium diet was liberalized to a moderately high sodium diet, the digoxin clearance increased by 70% and the serum digoxin levels decreased by 20%.
Diuresis-induced hypokalemia It is well known that hypokalemia is associated with sensitivity to digitalis and, thus, increases its toxicity , but it is not well appreciated that when the serum potassium is as low as 2 to 3 mEq/liter, the tubular secretion of digoxin is nearly blocked. Although thiazides and loop diuretic drugs themselves do not alter the kinetics of digoxin excretion, they induce a dose-dependent loss of potassium from the body, resulting in a decreased serum potassium concentration.
Potassium-sparing diuretic drugs Possible mechanisms for these observations include an increased tubular secretion of digoxin to account for the increased renal clearance and a decrease in the hepatic elimination rate of digoxin to account for the decrease in extra renal clearance. This combination of quinidine and spironolactone caused significant reductions in total body clearance of digoxin, no renal digoxin clearance and digoxin renal clearance beyond the reductions induced by either drug alone . The clinical significance of an anticipated elevation of steady state serum digoxin levels induced by the potassium-sparing diuretic drugs is not clear. The effects of the potassium-sparing diuretic drugs on steady state serum digoxin levels have not been adequately evaluated. The potassium sparing diuretic drugs, spironolactone, triamterene and amiloride, have been reported to induce changes in digoxin kinetics . Since the magnitude of this interaction of potassium- sparing diuretic drugs has not been es